FDA grants priority review to Bayer's Lynkuet for breast cancer use
Bayer announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application (sNDA) and granted Priority ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

